المؤلفون: Fonseca HAR; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Pereira AJ; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Nawa RK; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Sant'Anna VAR; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Almeida TF; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Guimarães HP; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Tognon AP; Hospital São Vicente de Paulo, Passo Fundo, RS, Brazil., Marques LM; Multidisciplinary Institute of Health, Universidade Federal da Bahia, Vitória da Conquista, BA, Brazil., Silva LSCD; Multidisciplinary Institute of Health, Universidade Federal da Bahia, Vitória da Conquista, BA, Brazil., Bittencourt RS; Multidisciplinary Institute of Health, Universidade Federal da Bahia, Vitória da Conquista, BA, Brazil., Gomes CP; Department of Microbiology, Universidade Estadual de Santa Cruz, Ilheús, BA, Brazil., Martins PA; Hospital Estadual Dr. Jayme Santos Neves, Serra, ES, Brazil., Oliveira AL; Hospital Estadual Dr. Jayme Santos Neves, Serra, ES, Brazil., Milan EP; Hospital Giselda Trigueiro, Natal, RN, Brazil., Dall'Orto FTC; Hospital Maternidade e Pronto Socorro Santa Lúcia, Poços de Caldas, MG, Brazil., Hoffman Filho CR; Hospital Regional Hans Dieter Schimdt, Joinville, SC, Brazil., Almeida G; Hospital de Emergência do Agreste Dr. Daniel Houly, Arapiraca, AL, Brazil., Hohmann FB; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Moia DDF; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Piano LPA; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Machado FP; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Soares RVP; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Damiani LP; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Assis SRL; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Amaro Junior E; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Rizzo LV; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Berwanger O; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

المصدر: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2024 Aug 09; Vol. 22, pp. eAO0652. Date of Electronic Publication: 2024 Aug 09 (Print Publication: 2024).

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Instituto de Ensino e Pesquisa Albert Einstein Country of Publication: Brazil NLM ID: 101281800 Publication Model: eCollection Cited Medium: Internet ISSN: 2317-6385 (Electronic) Linking ISSN: 16794508 NLM ISO Abbreviation: Einstein (Sao Paulo) Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/mortality , COVID-19*/epidemiology , Hospitalization*/statistics & numerical data, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Ambulatory Care/statistics & numerical data ; Brazil/epidemiology ; Cohort Studies ; Length of Stay/statistics & numerical data ; Outpatients/statistics & numerical data ; Prospective Studies ; Severity of Illness Index

المؤلفون: Fonseca HAR; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Furtado RHM; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil.; Cardiology Division, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701, São Paulo, Brazil.; Instituto do Coracao (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Enéas Carvalho de Aguiar, 44, São Paulo, Brazil., Zimerman A; Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211, Porto Alegre, Rio Grande do Sul, Brazil., Lemos PA; Cardiology Division, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701, São Paulo, Brazil., Franken M; Cardiology Division, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701, São Paulo, Brazil., Monfardini F; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Pedrosa RP; Pronto Socorro Cardiológico de Pernambuco, PROCAPE, Rua dos Palmares, SN, Recife, Pernambuco, Brazil., Patriota RLS; Pronto Socorro Cardiológico de Pernambuco, PROCAPE, Rua dos Palmares, SN, Recife, Pernambuco, Brazil., Passos LCS; Hospital Ana Nery, R. Saldanha Marinho, s/n, Salvador, Bahia, Brazil., Dall'Orto FTC; Hospital Santa Lúcia, Avenida Vereador Edmundo Cardillo, 3003, Poços de Caldas, Minas Gerais, Brazil., Hoffmann Filho CR; Hospital Regional Hans Dieter Schmidt, R. Xavier Arp, s/n - Boa Vista, Joinville, Santa Catarina, Brazil., Nascimento BR; Hospital Universitário Ciências Médicas, Rua dos Aimorés, 2896 - Santo Agostinho, Belo Horizonte, Minas Gerais, Brazil., Baldissera FA; Instituto de Pesquisas Médicas de Itajaí, Avenida Coronel Marcos Konder, 1111, Itajaí, Santa Catarina, Brazil., Pereira CAC; Instituto do Coracao (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Enéas Carvalho de Aguiar, 44, São Paulo, Brazil., Caramori PRA; Hospital São Lucas da PUCRS, Av Ipiranga, 6690, Porto Alegre, Rio Grande do Sul, Brazil., de Andrade PB; Irmandade da Santa Casa de Misericórdia de Marilia, Av. Vicente Ferreira, 828, Marília, São Paulo, Brazil., Esteves C; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Salim EF; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., da Silva JH; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Pedro IC; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Silva MCR; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., de Pedri EH; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Carioca ACRD; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., de Piano LPA; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Albuquerque CSN; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Moia DDF; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Momesso RGRAP; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Machado FP; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Damiani LP; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Soares RVP; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil., Schettino GP; Instituto de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, São Paulo, Brazil., Rizzo LV; Instituto de Ensino e Pesquisa, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, São Paulo, Brazil., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Enéas Carvalho de Aguiar, 44, São Paulo, Brazil., Berwanger O; Academic Research Organization, Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, 755, 4° andar, São Paulo 05652-900, Brazil.

المصدر: European heart journal [Eur Heart J] 2022 Nov 01; Vol. 43 (41), pp. 4378-4388.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Acute Coronary Syndrome*/therapy , Influenza, Human*/prevention & control , Myocardial Infarction*/prevention & control , Stroke*/prevention & control, Humans ; Vaccination ; Vaccines, Inactivated ; Treatment Outcome

المؤلفون: Cantor WJ; Department of Medicine, Southlake Regional Health Centre, University of Toronto, 581 Davis Drive, Newmarket, Toronto, Ontario L3Y 2P6, Canada. Electronic address: cantorw@rogers.com., Tan M; Department of Medicine, Canadian Heart Research Centre, Toronto, Ontario, Canada., Berwanger O; Academic Research Organization (ARO), Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil., Lavi S; Department of Medicine, London Health Sciences Centre, Western University, London, Ontario, Canada., White HD; Department of Medicine, Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Dehghani P; Department of Medicine, Prairie Vascular Research Network and Saskatchewan Health Authority, University of Saskatchewan, Regina, Saskatchewan, Canada., Tajer CD; Department of Medicine, Hospital de Alta Complejidad El Cruce, Buenos Aires, Argentina., Lopes RD; Department of Medicine, Duke Clinical Research Institute, Durham, NC, United States; Department of Medicine, Universidade Federal de São Paulo, São Paulo, Brazil., Moia DDF; Clinical Operations, Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Nicholls SJ; Department of Medicine, Monash Cardiovascular Research Centre, Monash University, Melbourne, Victoria, Australia., Parkhomenko A; Department of Medicine, Emergency Cardiology Department, Institute of Cardiology, Kiev, Ukraine., Averkov O; Department of Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Brass N; Department of Medicine, CK Hui Heart Centre, Edmonton, Alberta, Canada., Lutchmedial S; Department of Medicine, New Brunswick Heart Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Malaga G; Department of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru., Damiani LP; Clinical Operations, Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Piegas LS; Department of Medicine, Heart Hospital (HCor), São Paulo, Brazil., Granger CB; Department of Medicine, Duke Clinical Research Institute, Durham, NC, United States., Goodman SG; Department of Medicine, Canadian Heart Research Centre (CHRC) and Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.

المصدر: American heart journal [Am Heart J] 2022 Sep; Vol. 251, pp. 1-12. Date of Electronic Publication: 2022 May 06.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Percutaneous Coronary Intervention*/adverse effects , ST Elevation Myocardial Infarction*/therapy, Clopidogrel/therapeutic use ; Hemorrhage/chemically induced ; Humans ; Morphine/therapeutic use ; Platelet Aggregation Inhibitors/therapeutic use ; Thrombolytic Therapy ; Ticagrelor/therapeutic use ; Treatment Outcome

المؤلفون: Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA; School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia. Electronic address: mkosiborod@saint-lukes.org., Esterline R; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Furtado RHM; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Instituto do Coracao do Hospital das Clinicas da FMUSP, Sao Paulo, Brazil., Oscarsson J; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Gasparyan SB; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Koch GG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Martinez F; National University of Córdoba, Córdoba, Argentina., Mukhtar O; Experimental Medicine and Immunotherapeutics Division, Department of Medicine, University of Cambridge, Cambridge, UK., Verma S; Division of Cardiac Surgery, Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada; Department of Surgery and Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada., Chopra V; Max Super Speciality Hospital, New Delhi, India., Buenconsejo J; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Langkilde AM; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Ambery P; Late-stage Development, CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Tang F; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Gosch K; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Windsor SL; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Akin EE; George Clinical Inc, Overland Park, KS, USA., Soares RVP; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Moia DDF; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Aboudara M; Division of Pulmonary and Critical Care, Saint Luke's Health System, Kansas City, MO, USA., Hoffmann Filho CR; Hospital Regional Hans Dieter Schmidt, Joinville, Brazil., Feitosa ADM; PROCAPE, Recife, Brazil., Fonseca A; Hospital Coracao do Brasil, Brasília, Brazil., Garla V; Department of Endocrinology, Diabetes and Metabolism, Internal Medicine, University of Mississippi Medical Center, Jackson, MS, USA; Mississippi Center for Clinical and Translational Research, Jackson, MI, USA., Gordon RA; North Shore University Health System, Evanston, IL, USA., Javaheri A; Washington University School of Medicine, St Louis, MO, USA., Jaeger CP; Hospital Mãe de Deus, Porto Alegre, Brazil., Leaes PE; Irmandade Da Santa Casa de Misericórdia de Porto Alegre, Brazil., Nassif M; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA., Pursley M; Heart Group of the Eastern Shore, Fairhope, AL, USA., Silveira FS; Centro de Pesquisa Clínica do Coração, Aracaju, Brazil., Barroso WKS; Liga de Hipertensão Arterial -Universidade Federal de Goiás, Brazil; HCAMP-Secretaria Estadual de Saúde, Goiás, Brazil., Lazcano Soto JR; Instituto de Investigaciones Aplicadas a la Neurociencia AC, Durango City, Mexico., Nigro Maia L; Centro Integrado de Pesquisas, Hospital de Base, São José do Rio Preto, Brazil., Berwanger O; Academic Research Organization-Hospital Israelita Albert Einstein, Sao Paulo, Brazil.

المصدر: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Sep; Vol. 9 (9), pp. 586-594. Date of Electronic Publication: 2021 Jul 21.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE

مواضيع طبية MeSH: Cardiometabolic Risk Factors*, Benzhydryl Compounds/*administration & dosage , COVID-19/*complications , Glucosides/*administration & dosage , Multiple Organ Failure/*prevention & control , Sodium-Glucose Transporter 2 Inhibitors/*administration & dosage, Aged ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Multiple Organ Failure/complications ; Treatment Outcome

المؤلفون: Guimarães PO; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Quirk D; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Furtado RH; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Maia LN; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Saraiva JF; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Antunes MO; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Kalil Filho R; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Junior VM; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Soeiro AM; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Tognon AP; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Veiga VC; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Martins PA; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Moia DDF; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Sampaio BS; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Assis SRL; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Soares RVP; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Piano LPA; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Castilho K; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Momesso RGRAP; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Monfardini F; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Guimarães HP; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Ponce de Leon D; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Dulcine M; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Pinheiro MRT; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Gunay LM; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Deuring JJ; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Rizzo LV; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Koncz T; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.)., Berwanger O; From the Hospital Israelita Albert Einstein (P.O.G., R.H.F., D.D.F.M., B.S.S., S.R.L.A., R.V.P.S., L.P.A.P., K.C., R.G.R.A.P.M., F.M., H.P.G., L.V.R., O.B.), the Heart Institute, InCor, University of São Paulo Medical School (R.H.F., R.K.F., V.M.J.), BP Mirante-A Beneficência Portuguesa de São Paulo (A.M.S.), BP-A Beneficência Portuguesa de São Paulo (V.C.V.), and Pfizer (M.D., M.R.T.P.), São Paulo, Centro Integrado de Pesquisa, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto (L.N.M.), Pontifícia Universidade Católica de Campinas, Campinas (J.F.S.), Hospital Universitário São Francisco de Assis na Providência de Deus and Irmandade do Senhor Bom Jesus dos Passos da Santa Casa de Misericórida de Bragança Paulista, Bragança Paulista (M.O.A.), Hospital São Vicente de Paulo, Passo Fundo (A.P.T.), and Hospital Estadual Jayme dos Santos Neves, Vila Velha (P.A.M.) - all in Brazil; Pfizer, Collegeville, PA (D.Q.); Pfizer, Lima, Peru (D.P.L.); Pfizer, Istanbul, Turkey (L.M.G.); Pfizer, Rotterdam, the Netherlands (J.J.D.); and Pfizer, New York (T.K.).

مؤلفون مشاركون: STOP-COVID Trial Investigators

المصدر: The New England journal of medicine [N Engl J Med] 2021 Jul 29; Vol. 385 (5), pp. 406-415. Date of Electronic Publication: 2021 Jun 16.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19 Drug Treatment*, Glucocorticoids/*therapeutic use , Janus Kinase Inhibitors/*therapeutic use , Piperidines/*therapeutic use , Pyrimidines/*therapeutic use, Adult ; Aged ; Antiviral Agents/therapeutic use ; Brazil ; COVID-19/complications ; COVID-19/mortality ; COVID-19/therapy ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Hospitalization ; Humans ; Incidence ; Janus Kinase 3/antagonists & inhibitors ; Janus Kinase Inhibitors/adverse effects ; Male ; Middle Aged ; Oxygen Inhalation Therapy ; Piperidines/adverse effects ; Pyrimidines/adverse effects ; Respiratory Insufficiency/epidemiology ; Respiratory Insufficiency/etiology

المؤلفون: Furtado RHM; Hospital Israelita Albert Einstein, São Paulo, Brazil; Instituto do Coração, Hospital das Clinicas da Faculdade de Medicina, Universidade de São Paulo, Brazil., Berwanger O; Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: otavio.berwanger@einstein.br., Fonseca HA; Hospital Israelita Albert Einstein, São Paulo, Brazil., Corrêa TD; Hospital Israelita Albert Einstein, São Paulo, Brazil; Brazilian Research in Intensive Care Network, São Paulo, Brazil., Ferraz LR; Hospital Israelita Albert Einstein, São Paulo, Brazil., Lapa MG; Hospital Israelita Albert Einstein, São Paulo, Brazil., Zampieri FG; Brazilian Research in Intensive Care Network, São Paulo, Brazil; HCor Research Institute, São Paulo, Brazil., Veiga VC; Brazilian Research in Intensive Care Network, São Paulo, Brazil; BP-A Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Azevedo LCP; Brazilian Research in Intensive Care Network, São Paulo, Brazil; Hospital Sírio Libanês Research and Education Institute, São Paulo, Brazil., Rosa RG; Brazilian Research in Intensive Care Network, São Paulo, Brazil; Hospital Moinhos de Vento, Porto Alegre, Brazil., Lopes RD; Brazilian Clinical Research Institute, São Paulo, Brazil; Duke University Medical Centre, Duke Clinical Research Institute, Durham, NC, USA., Avezum A; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil., Manoel ALO; Hospital Moyses Deustche (MBoi Mirim), São Paulo, Brazil., Piza FMT; Hospital Moyses Deustche (MBoi Mirim), São Paulo, Brazil., Martins PA; Hospital Estadual Jayme dos Santos Neves, Serra, Brazil., Lisboa TC; Hospital de Clínicas, Porto Alegre, Brazil., Pereira AJ; Hospital Israelita Albert Einstein, São Paulo, Brazil; Hospital Vila Santa Catarina, São Paulo, Brazil., Olivato GB; Hospital Israelita Albert Einstein, São Paulo, Brazil; Hospital Vila Santa Catarina, São Paulo, Brazil., Dantas VCS; Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil., Milan EP; Hospital Giselda Trigueiro, Natal, Brazil., Gebara OCE; Hospital Santa Paula, São Paulo, Brazil., Amazonas RB; EMS Pharma, Hortolândia, Brazil., Oliveira MB; EMS Pharma, Hortolândia, Brazil., Soares RVP; Hospital Israelita Albert Einstein, São Paulo, Brazil., Moia DDF; Hospital Israelita Albert Einstein, São Paulo, Brazil., Piano LPA; Hospital Israelita Albert Einstein, São Paulo, Brazil., Castilho K; Hospital Israelita Albert Einstein, São Paulo, Brazil., Momesso RGRAP; Hospital Israelita Albert Einstein, São Paulo, Brazil., Schettino GPP; Hospital Israelita Albert Einstein, São Paulo, Brazil., Rizzo LV; Hospital Israelita Albert Einstein, São Paulo, Brazil., Neto AS; Hospital Israelita Albert Einstein, São Paulo, Brazil; Brazilian Research in Intensive Care Network, São Paulo, Brazil; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Machado FR; Brazilian Research in Intensive Care Network, São Paulo, Brazil; Department of Anesthesiology, Pain and Intensive Care Medicine, Universidade Federal de São Paulo, São Paulo, Brazil., Cavalcanti AB; Brazilian Research in Intensive Care Network, São Paulo, Brazil; HCor Research Institute, São Paulo, Brazil.

مؤلفون مشاركون: COALITION COVID-19 Brazil II Investigators

المصدر: Lancet (London, England) [Lancet] 2020 Oct 03; Vol. 396 (10256), pp. 959-967. Date of Electronic Publication: 2020 Sep 05.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*therapeutic use , Azithromycin/*therapeutic use , Coronavirus Infections/*drug therapy , Hydroxychloroquine/*therapeutic use , Pneumonia, Viral/*drug therapy, Aged ; Antiviral Agents/adverse effects ; Azithromycin/adverse effects ; Betacoronavirus ; Brazil/epidemiology ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/mortality ; Drug Therapy, Combination ; Female ; Humans ; Hydroxychloroquine/adverse effects ; Length of Stay ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/mortality ; Respiratory Therapy ; SARS-CoV-2 ; Standard of Care ; Treatment Outcome

المؤلفون: Berwanger O; Research Institute, Heart Hospital (HCor), São Paulo, Brazil. Electronic address: otavioberwanger@gmail.com., Lopes RD; Duke Clinical Research Institute, Durham, North Carolina; Universidade Federal de São Paulo, São Paulo, Brazil., Moia DDF; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Fonseca FA; Universidade Federal de São Paulo, São Paulo, Brazil., Jiang L; Fuwai Hospital, Beijing, China., Goodman SG; Canadian Heart Research Centre (CHRC) and Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Nicholls SJ; Monash Cardiovascular Research Centre, Monash University, Melbourne, Victoria, Australia., Parkhomenko A; Institute of Cardiology, Emergency Cardiology Department, Kiev, Ukraine., Averkov O; Pirogov Russian National Research Medical University, Moscow, Russia., Tajer C; Hospital de Alta Complejidad El Cruce, Buenos Aires, Argentina., Malaga G; School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru., Saraiva JFK; Hospital e Maternidade Celso Pierro, Campinas, Brazil., Guimaraes HP; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., de Barros E Silva PGM; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Damiani LP; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Santos RHN; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Paisani DM; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Miranda TA; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Valeis N; Research Institute, Heart Hospital (HCor), São Paulo, Brazil., Piegas LS; Heart Hospital (HCor), São Paulo, Brazil., Granger CB; Duke Clinical Research Institute, Durham, North Carolina., White HD; Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand., Nicolau JC; Instituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

المصدر: Journal of the American College of Cardiology [J Am Coll Cardiol] 2019 Jun 11; Vol. 73 (22), pp. 2819-2828. Date of Electronic Publication: 2019 Mar 18.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Clopidogrel/*therapeutic use , ST Elevation Myocardial Infarction/*drug therapy , Thrombolytic Therapy/*methods , Ticagrelor/*therapeutic use, Aged ; Cause of Death ; Clopidogrel/adverse effects ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Long-Term Care ; Male ; Middle Aged ; ST Elevation Myocardial Infarction/mortality ; Survival Analysis ; Ticagrelor/adverse effects ; Treatment Outcome

المؤلفون: Berwanger O; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil. Electronic address: oberwanger@hcor.com.br., Nicolau JC; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Carvalho AC; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Jiang L; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Goodman S; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Nicholls SJ; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Parkhomenko A; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Averkov O; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Tajer C; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Malaga G; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Kerr Saraiva JF; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Fonseca F; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Guimaraes HP; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., de Barros E Silva PGM; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Damiani LP; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Paisani DM; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Lasagno CMR; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Candido CT; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Valeis N; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Moia DDF; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Piegas LS; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Granger CB; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., White H; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil., Lopes RD; Research Institute - Heart Hospital (HCor), Rua Abílio Soares 250, 12th floor, CEP: 04005-000, São Paulo, SP, Brazil.

المصدر: American heart journal [Am Heart J] 2018 Aug; Vol. 202, pp. 89-96. Date of Electronic Publication: 2018 Mar 03.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Clopidogrel/*therapeutic use , Fibrinolytic Agents/*therapeutic use , Hemorrhage/*chemically induced , Purinergic P2Y Receptor Antagonists/*therapeutic use , Ticagrelor/*therapeutic use, Adult ; Aged ; Anticoagulants/therapeutic use ; Clopidogrel/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Intention to Treat Analysis ; Male ; Middle Aged ; Prospective Studies ; Purinergic P2Y Receptor Antagonists/adverse effects ; Research Design ; ST Elevation Myocardial Infarction ; Single-Blind Method ; Ticagrelor/adverse effects

المؤلفون: Berwanger O; Research Institute, Heart Hospital, São Paulo, Brazil., Nicolau JC; Instituto do Coração, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Carvalho AC; Universidade Federal de São Paulo, São Paulo, Brazil., Jiang L; Fuwai Hospital, Beijing, China., Goodman SG; Canadian Heart Research Centre, Toronto, Canada., Nicholls SJ; South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia., Parkhomenko A; Institute of Cardiology, Emergency Cardiology Department, Kiev, Ukraine., Averkov O; Pirogov Russian National Research Medical University, Moscow, Russia., Tajer C; Hospital de Alta Complejidad El Cruce, Buenos Aires, Argentina., Malaga G; Universidad Peruana Cayetano Heredia, Lima, Peru., Saraiva JFK; Hospital e Maternidade Celso Pierro, Campinas, Brazil., Fonseca FA; Universidade Federal de São Paulo, São Paulo, Brazil., De Luca FA; Hospital Geral do Grajaú, São Paulo, Brazil., Guimaraes HP; Research Institute, Heart Hospital, São Paulo, Brazil., de Barros E Silva PGM; Research Institute, Heart Hospital, São Paulo, Brazil., Damiani LP; Research Institute, Heart Hospital, São Paulo, Brazil., Paisani DM; Research Institute, Heart Hospital, São Paulo, Brazil., Lasagno CMR; Research Institute, Heart Hospital, São Paulo, Brazil., Candido CT; Research Institute, Heart Hospital, São Paulo, Brazil., Valeis N; Research Institute, Heart Hospital, São Paulo, Brazil., Moia DDF; Research Institute, Heart Hospital, São Paulo, Brazil., Piegas LS; Heart Hospital, São Paulo, Brazil., Granger CB; Duke University Medical Center, Durham, North Carolina., White HD; Auckland City Hospital, Auckland District Health Board, Auckland, New Zealand., Lopes RD; Duke University Medical Center, Durham, North Carolina.

مؤلفون مشاركون: TREAT Study Group

المصدر: JAMA cardiology [JAMA Cardiol] 2018 May 01; Vol. 3 (5), pp. 391-399.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Clopidogrel/*therapeutic use , Fibrinolytic Agents/*therapeutic use , Myocardial Infarction/*drug therapy , Ticagrelor/*therapeutic use, Aged ; Clopidogrel/adverse effects ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Middle Aged ; Ticagrelor/adverse effects